Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10.
Published December 24, 2025 · Recall initiated: November 26, 2025
Summary
FDA records drug Class III recall D-0237-2026, published December 24, 2025 and initiated November 26, 2025. Recalling firm: SOMERSET THERAPEUTICS LLC; Status: Ongoing; Reported quantity: 28,660 20mL vials; Lot: Lot #: A250020, Exp Date 06/30/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent product:out of specification assay results observed during long term stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if CISATRACURIUM BESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CISATRACURIUM BESYLATE
- Manufacturer
- SOMERSET THERAPEUTICS LLC
- Distributor
- Nationwide in the USA
- UPC
- 0370069141014
- Lot
- Lot #: A250020, Exp Date 06/30/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, RxDecember 24, 2025
- FDACisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only,December 24, 2025
- FDABaclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDCDecember 24, 2025
- FDAOndansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged byDecember 24, 2025
- FDAOraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4December 24, 2025
- FDACisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05),March 3, 2021
Questions about this recall
Was Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10. recalled?
Yes. FDA published recall D-0237-2026 on December 24, 2025. Reported hazard: Subpotent product:out of specification assay results observed during long term stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CISATRACURIUM BESYLATE. UPC: 0370069141014.